|By Marketwired .||
|July 29, 2014 07:11 AM EDT||
WATERLOO, ONTARIO -- (Marketwired) -- 07/29/14 -- Intellijoint Surgical Inc. (formerly, Avenir Medical), innovator in developing smart tools to improve joint replacement surgery, announced today that it has obtained clearance from the US Food and Drug Administration for its flagship product, Intellijoint HIP.
"We're already approved in Canada, now we can begin marketing Intellijoint HIP to hospitals and orthopedic surgeons in the United States," said Armen Bakirtzian, CEO of Intellijoint. "In the US, similar to Canada, our initial marketing plan is to work closely with certain leading surgeons and hospitals in specific geographic areas. In parallel, we are solidifying alliances with major implant companies while continuing to expand our product line."
"There are over a half million hip replacements a year in North America, and studies find that 30% of patients are dissatisfied with their surgery mainly due to avoidable leg length disparities, implant loosening and failures," said Dr. Wayne Paprosky, Professor and orthopedic surgeon at Rush Medical Center in Chicago, and member of Intellijoint's Scientific Advisory Board. "We are very pleased to now be able to use Intellijoint HIP to enhance hip replacement surgery and benefit patients in the US."
Intellijoint HIP is a smart tool used to guide surgeons during hip replacement surgery. Its two miniature sensors are placed in the sterile field and communicate with a portable display. Controlled by the surgeon, it quantifies the measurements, often left to subjective judgment, required for selecting and positioning hip implants.
Adding only a few minutes to surgery, Intellijoint HIP assures surgeons and patients of obtaining the correct leg length and hip offset, which are the main sources of patient dissatisfaction in hip replacement. For hospitals, currently under pressure to use quality and efficiency metrics, it can help reduce costs and liabilities of implant failures and repeat surgeries that add over $1 billion a year to the US healthcare system.
About Intellijoint Surgical Inc.
Intellijoint is an early stage orthopedic medical device company committed to assist orthopedic surgeons specialized in joint arthroplasty to improve patient care. Focusing first on hip surgery, the Company develops and commercializes miniaturized, smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes.
Contact: CEO: Armen Bakirtzian
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
Dec. 10, 2016 06:00 AM EST Reads: 693
Dec. 10, 2016 04:45 AM EST Reads: 1,092
Dec. 10, 2016 04:30 AM EST Reads: 531
Dec. 10, 2016 04:15 AM EST Reads: 1,387
Dec. 10, 2016 04:15 AM EST Reads: 553
Dec. 10, 2016 04:00 AM EST Reads: 5,522
Dec. 10, 2016 04:00 AM EST Reads: 5,316
Dec. 10, 2016 03:15 AM EST Reads: 488
Dec. 10, 2016 02:45 AM EST Reads: 2,270
Dec. 10, 2016 02:15 AM EST Reads: 795
Dec. 10, 2016 02:00 AM EST Reads: 1,995
Dec. 10, 2016 02:00 AM EST Reads: 625
Dec. 10, 2016 01:30 AM EST Reads: 793
Dec. 10, 2016 01:30 AM EST Reads: 4,001
Dec. 10, 2016 01:15 AM EST Reads: 1,225